ARTICLE | Clinical News
Angiomax bivalirudin regulatory update
June 20, 2005 7:00 AM UTC
FDA approved an sNDA for Angiomax bivalirudin injection with provisional glycoprotein IIb/IIIa inhibitors as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI). The throm...